The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease course will provide theoretical education and practical experience in the management of pump therapies for advanced Parkinson’s disease (Levodopa carbidopa intestinal gel and apomorphine). Additionally, the course will include innovations in the infusion therapies field e.g. Levodopa-Entacapone-Carbidopa Intestinal Gel and subcutaneous levodopa pumps. The course includes lectures on the development of the therapies, their experimental basis, effects and side effects, practical management, interactive workshops on patient selection and practical management, as well as a hands-on course on pump management.
By registering for this course, you agree to the statement provided in the section below labeled 'Assumption of Risk and Liability - COVID'.
Faculty
Course Directors
Katarzyna Smilowska, MD, PhD - Department of Neurology, Silesian Center of Neurology, Katowice, Poland
Tove Henriksen, MD - Bispebjerg Hospital, Copenhagen, Denmark
Faculty
Angelo Antonini, MD, PhD - University of Padua, Padua, Italy
Marek Balaz, MD, PhD - St. Anne's University Hospital, Brno, Czech Republic
Bas Bloem, MD, PhD, FRCPE, Radboud University Medical Center, Nijmegen, Netherlands
K. Ray Chaudhuri, FRCP, DSc, FEAN - King's College, London, United Kingdom
Per Odin, MD, PhD - Lund University, Lund, Sweden
Miriam Parry - King's College Hospital NHS Trust, London, United Kingdom
Karolina Poplawska-Domaszewicz, MD, PhD - Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland
Anna Roszmann, PhD, MA, RN - Medical University of Gdansk, Gdansk, Poland
Matej Škorvánek, MD, PhD - University of P. J. Safarik, Košice, Slovakia